ABSTRACT: Upgrading wastewater treatment plants (WWTPs) with advanced technologies is one key strategy to reduce micropollutant emissions. Given the complex chemical composition of wastewater, toxicity removal is an integral parameter to assess the performance of WWTPs. Thus, the goal of this systematic review is to evaluate how effectively ozonation and activated carbon remove in vitro and in vivo toxicity. Out of 2464 publications, we extracted 46 relevant studies conducted at 22 pilot or full-scale WWTPs. We performed a quantitative and qualitative evaluation of in vitro (100 assays) and in vivo data (20 species), respectively. Data is more abundant on ozonation (573 data points) than on an activated carbon treatment (162 data points), and certain in vitro end points (especially estrogenicity) and in vivo models (e.g., daphnids) dominate. The literature shows that while a conventional treatment effectively reduces toxicity, residual effects in the effluents may represent a risk to the receiving ecosystem on the basis of effectbased trigger values. In general, an upgrade to ozonation or activated carbon treatment will significantly increase toxicity removal with similar performance. Nevertheless, ozonation generates toxic transformation products that can be removed by a post-treatment. By assessing the growing body of effect-based studies, we identify sensitive and underrepresented end points and species and provide guidance for future research.
INTRODUCTION
Micropollutants affect the ecological status of freshwater ecosystems.
1,2 In addition to significant diffuse sources, such as runoff from urban and agricultural areas, 3,4 the discharge of conventionally treated wastewater represents a major point source of pollutants entering aquatic ecosystems. 5 Accordingly, numerous studies demonstrate a negative impact of wastewater discharge on the receiving ecosystem, such as a decline of biodiversity and essential ecosystem functions (e.g., leaf litter decomposition).
6−8 Moreover, the continuous discharge of pollutants by wastewater treatment plants (WWTPs) may also affect drinking water quality, in particular in densely populated regions, where groundwater is replenished by bank filtration.
9
For instance, in the Berlin metropolitan region, several wastewater-borne compounds have been detected in ground and tap water. 10, 11 To improve the water quality of receiving aquatic ecosystems and at the same time protect drinking water resources, conventional WWTPs based on an activated sludge treatment can be upgraded with oxidative and sorptive technologies.
12 Full-scale trials at WWTPs demonstrate that both ozonation and activated carbon treatment reduce the load of a broad range of micropollutants by over 80%. 13, 14 Consequently and following a precautionary approach, several countries either are considering or have already started to upgrade their WWTPs. Switzerland has taken a pioneering role by implementing a national policy to upgrade 123 of their 750 WWTPs, which enjoys, despite the high implementation and maintenance cost, widespread public acceptance. 15 Chemical analysis is the norm for water quality assessment. Nevertheless, an evaluation of wastewater treatment technologies on a per-chemical basis covers only a small fraction of known micropollutants and may, thus, not represent the actual removal performance. In addition, gaps in knowledge regarding the occurrence of unknown compounds, transformation products (TPs), 16 and potential mixture effects exist. 17 To address these limitations, complementary effect-based measurements are increasingly integrated into the evaluation of advanced wastewater treatment technologies. In contrast to chemical analysis, bioassays determine the actual toxicity, integrating the joint effects of all chemicals, including the unknowns and TPs.
While for some specific bioassays (e.g., estrogenic activity), the effect is caused by a few potent chemicals, for most bioassays, only a minor fraction can be explained by the detected chemicals. 4, 18 Accordingly, several studies on wastewater or surface waters reported a marked discrepancy between the toxicity observed in bioassays and the toxicity predicted based on chemical analysis, even when a broad set of target micropollutants (>400) was included. 4, 18, 19 Hence, the integration of effect-based measurements into the assessment of wastewater treatment technologies is crucial to obtain a comprehensive picture of their performance in removing toxicity rather than single chemicals. Accordingly, various in vitro and in vivo bioassays have been included in monitoring studies at advanced wastewater treatment pilot or full-scale plants.
While some reviews of targeting micropollutant removal exist, 20−22 a review addressing effect-based studies is lacking. Therefore, the aim of this systematic review is (1) to evaluate the toxicity removal by advanced wastewater treatment and (2) to provide an inventory of the in vitro and in vivo bioassays with the aim of (3) identifying underrepresented and sensitive end points and species. On this basis, we highlight (4) knowledge gaps to guide future research. We, thus, performed a systematic review of effect-based studies and focused on technologies that have already been applied to reduce the emission of chemicals to aquatic ecosystems. Here, ozonation and activated carbon treatment represent the most common and mature technologies that are efficient, technically feasible, and sufficiently cost-effective. 12 We excluded membrane technologies (e.g., ultrafiltration or reverse osmosis) and advanced oxidation processes (e.g., UV/H 2 O 2 ) because these are mainly applied for water reuse or have not been tested in full-scale for wastewater treatment. 23 The lessons learned are useful to benchmark existing technologies, guide future research, and evaluate other advanced wastewater treatment technologies.
MATERIAL AND METHODS
2.1. Literature Search. We searched Web of Science (Core Collection) for effect-based studies investigating ozonation or activated carbon treatment using the following search strings: (ozon* OR activ* carbon*) AND (wastew* OR sewage*) AND (ecotox* OR tox* OR in vitro OR in vivo) (accessed July 12, 2018). This search returned 2456 publications, from which we removed studies published before 2000, reviews, and duplicates ( Figure 1 ). To address the goals of the EU Water Framework Directive and as part of the implementation of the Swiss policy to upgrade their WWTPs, several projects have assessed advanced wastewater treatment. Thus, we complemented the peer-reviewed literature with nine relevant project reports. 24−32 2.2. Eligibility Criteria. To ensure that the data reflects realistic scenarios and is comparable, we exclusively focused on studies that investigated an ozonation or activated carbon treatment at pilot or full-scale implemented at municipal WWTPs. Accordingly, we excluded all studies that (1) did not use bioassays, (2) investigated other treatment technologies (e.g., reverse osmosis), (3) were performed at lab-scale, or (4) investigated hospital or industrial wastewaters.
2.3. Selection of Studies. Two authors (J.V., M.W.) conducted an independent and blinded screening of the literature according to the criteria provided above. For this, we used Rayyan for systematic reviews (https://rayyan.qcri.org). 33 After the initial screening of titles and abstracts, we selected 164 studies for full-text review (Figure 1 ). In case of conflicting decisions during initial screening, the respective study was included in the full text screening. After the full-text screening, we excluded 118 publications on the basis of the above criteria and categorized the remaining 46 studies in two groups (in vitro and in vivo data). While the majority of studies included both into their assessment (46%), 24% and 30% of the studies focused exclusively on in vitro and in vivo bioassays, respectively. We decided not to perform a quality assessment of the selected studies to keep the database broad. However, all in vitro studies included reference compounds used for bioanalytical equivalent concentrations (BEQ) estimation, and all in vivo studies included negative controls and were mostly performed in accordance with international guidelines.
2.4. Data Extraction. Bioassay data from the final set of studies were extracted into an Excel database (see Excel file in Supporting Information (SI)) and categorized according to the location of the pilot plant, the respective in vitro or in vivo end point, as well as to the different treatment types: (1) WWTP influent (INF), (2) conventional activated sludge treatment (CT) and subsequent (3) ozonation (ozone), (4) combination of ozonation and post-treatment (ozone + PT), or (5) activated carbon treatment (AC). If AC was performed subsequent to ozonation, we treated this data as ozone + PT. To provide a general overview, we pooled the data for each treatment type regardless of location-specific differences (e.g., operation parameters, ozone doses). Furthermore, we pooled the data from the different PTs after ozonation (e.g., sand filtration). Nevertheless, we collected all technological specifications of the WWTPs and the standard wastewater parameters (Tables S2−S6) . Moreover, because parts of the data from the project reports have also been published in research articles, we compared all bioassay data from the same WWTP and removed duplicates.
2.5. Data Analysis. We performed a quantitative evaluation of the in vitro data by calculating removal effectiveness for the different treatments and end points. The majority of studies reported BEQs (e.g., 17β-estradiol equivalent concentration in ng/L (EEQ)). Furthermore, some studies reported their results as effect concentrations (EC) in units of relative enrichment factor (REF) 34 or as receptor activation and inhibition. We calculated the removal effectiveness (% toxicity reduction) by comparing the corresponding data points for CT to INF and the advanced wastewater treatment to CT (see equations in SI section 3.1) using the mean toxicity level reported as BEQ or EC for individual samples (e.g., one-week mixture sample). Otherwise, we either used the reported overall removal or performed the calculation based on the given overall mean values. For values below the limit of detection (LOD), the removal effectiveness was calculated using the LOD. The individual calculation for each study is presented in the Excel file (SI). To test for significant differences between the treatments, we applied Kruskal−Wallis with Dunn's post hoc tests using GraphPad Prism 7.0 (GraphPad Software, San Diego, CA). A p < 0.05 was considered significant.
For in vitro mutagenicity and all in vivo end points, a quantitative evaluation was hampered by differences in the data presentation and reporting (e.g., lack of raw data, EC 20 or LOEC). Thus, we were unable to calculate removal effectiveness and performed a qualitative evaluation instead. We recorded the number of experiments in each study reporting either null or adverse effects according to treatment and end points.
REMOVAL OF IN VITRO TOXICITY
In vitro bioassays provide mechanistic insights, are ethically sound and economically favorable and offer a high-throughput capability. 36 They are, therefore, increasingly applied to assess water quality and wastewater treatment technologies. However, several challenges and limitations of an effect-based assessment by in vitro bioassays exist. The sample preparation can significantly affect the outcomes of a bioassay.
23, 37 For instance, solid-phase extraction (SPE) inevitability leads to a loss of chemicals present in the original sample, in particular of substances with high polarity. 38 Because the causative compounds often remain unknown, an optimization of SPE to extract the toxicity remains challenging. Hence, even though several studies demonstrated an adequate effect recovery by SPE, 39, 40 a complete recovery of active compounds can never be guaranteed. 41 However, an extraction of water samples is often necessary (1) to increase the probability of detecting toxicity with regard to the sensitivity of an assay, (2) to remove interfering matrix components (nutrients, salts, pathogens), and (3) to conserve the sample for later analysis. Accordingly, 30/31 studies containing in vitro data analyzed extracted wastewater. Thus, for the review, we focused on the results of SPE-extracted wastewater samples.
Moreover, the assessment by in vitro bioassays can result in false negative and positive effects. 42 Thus, to detect or exclude potential artifacts, quality controls (e.g., adequate blanks and reference compounds), as well as the determination of confounding factors (e.g., DOC or slight cytotoxicity) in the samples, should be included. The latter is particularly crucial for the investigation of hormone receptor antagonism. 43 However, a coherent approach is lacking, and only a few in vitro bioassays have been standardized by OECD or ISO. In addition, a consensus of a uniform data processing and reporting does not exist, which complicates the comparability of results. 44 This can be improved by agreeing on standardized data evaluation processes. 44, 45 Finally, the most significant challenge is to predict the impacts on whole organisms and, a fortifori, on whole ecosystems on the basis of in vitro data. Sample enrichment and highly sensitive cell lines enable the detection of effects even in samples with a low chemical burden (e.g., drinking water). 34 Hence, the detection of an effect does not necessarily translate to an adverse effect in wildlife or human. 46 In addition, several other factors hamper the interpretation of in vitro effects. For instance, in vitro bioassays usually do not cover toxicokinetic processes (i.e., detoxification, metabolic activation), as well as tissue-or organ-specific effects. 23 Accordingly, although they represent fast and sensitive screening tools, they cannot readily replace in vivo experiments. 47 Nevertheless, several studies successfully linked in vitro and in vivo effects, such as the prediction of in vivo vitellogenin induction from in vitro estrogenicity data. 48−50 Accordingly, effect-based trigger values (EBT), which facilitate a decision regarding whether an observed in vitro effect is acceptable or not, have been proposed for water quality monitoring on the basis of read-across approaches from existing guideline values and effect data for single chemicals. 46, 51, 52 3.1. Data Availability. Wastewater triggers various mechanisms of action in a battery of in vitro bioassays. 4 Thus, a broad spectrum of assays for multiple relevant end points should be applied to evaluate wastewater treatment technologies. On the basis of our selection criteria, we identified and analyzed 31 studies containing data from 100 in vitro assays. We excluded cytotoxicity assays because the results vary with the cell line and are hard to compare, and the Microtox assay is often more sensitive. 53 These studies cover 28 end points, including several endocrine end points, induction of xenobiotic metabolism, neurotoxicity, phytotoxicity, oxidative stress response, baseline toxicity, as well as genotoxicity and mutagenicity (Tables S7 and  S8) . 13,24,25,27−32,34,54−74 By far the best-studied end point is estrogenicity (22 out of 31 studies), followed by genotoxicity (18), mutagenicity (12), phytotoxicity(11), bacterial toxicity (11), androgenicity (11), antiandrogenicity (9), aryl-hydrocarbon receptor (AhR) activity (8), antiestrogenicity (7), as well as acetylcholinesterase (AchE) inhibition (4) and glucocorticoid and thyroid activity (4). For all other end points, only data from less than four studies was available.
All studies reported toxicity in at least one assay, while 41 assays were negative throughout all studies (Tables S7 and S8 ). For the remaining 59 assays, we extracted 647 data points for the calculation of removal effectiveness of the advanced treatment technologies (ozone, 243; ozone + PT, 325; AC, 79). Moreover, many studies did not analyze the influent of the conventional treatment (CT), reducing the data for the calculation of the removal by the CT (138 data points) compared to the advanced wastewater treatment technologies.
3.2. Endocrine End Points. In total, 54 in vitro bioassays for 13 endocrine end points were applied to investigate the removal of endocrine disrupting chemicals (EDCs), which "can interfere with any aspect of hormone action" 75 and include a vast and diverse group of anthropogenic chemicals. 76 There is increasing evidence that exposure to EDCs negatively affects wildlife at comparatively low concentrations. 36, 77 Here, wastewater discharge is an important point source. As a prominent example, wild fish populations downstream of WWTPs have been feminized. 78, 79 This intersex phenomenon in male fish is often associated with estrogens or estrogen-like chemicals in the treated effluents. 79 Nonetheless, a range of studies suggests that several other factors contribute, such as the exposure to antiandrogens 80 and to chemicals acting through other mechanisms than classical steroid receptors. 82−85 Despite this effective removal, the remaining estrogenicity of the effluents (median of 1.77 ng EEQ/L) may still induce adverse effects on organisms in the receiving water with regard to the low predicted no effect concentrations of 0.1 and 2 ng/L for 17α-ethinylestradiol (EE2) and 17β-estradiol (E2), respectively. 86 Both advanced wastewater treatment technologies eliminate the residual estrogenicity (Figure 2 ). While ozonation (91.7%) is more effective in removing estrogenicity than AC (75.0%), this difference is not significant (p = 0.08, Table S9 ).
3.2.2. Androgenicity. Nine different assays for androgenicity were applied in 11 studies. 25, 31, 34, [54] [55] [56] [57] 59, 62, 67, 74 Here, the CT almost completely removes the androgenicity (median removal of 98.6%, tab. 1), which is in line with previously reported values. 83 Thus, in many cases, a further reduction of androgenicity by an advanced wastewater treatment technology is not detectable. 34, 54, 59, 62, 67 If low residual activity exists, both technologies further reduce the androgenicity with a median removal of 43.2% and 54.6% for ozonation and AC, respectively (Figure 2) .
3.2.3. Progestogenic and Glucocorticoid Activity. Since they are widely used as pharmaceuticals, various glucocorticoids, mineralocorticoids, and progestogens have been frequently detected in WWTP effluents and surface waters. 87, 88 Accordingly, glucocorticoid and progestogenic activity can be detected in conventionally treated wastewater and surface waters. 83,89−93 Hence, these end points should also be considered when evaluating advanced wastewater treatment technologies because of their known effects on fish health 94, 95 and increased potency when co-occurring with estrogens and androgens. 96, 97 However, only three studies investigated progestogenic activity (2 assays) 31, 34, 62 and four studies glucocorticoid activity (5 assays). 31, 34, 59, 62 Influent samples were only analyzed in one pilot plant. 31 On the basis of this study, CT leads to a formation of progestogenic activity (−273%) and is ineffective to remove glucocorticoid activity (16.4%, Table 1), which is in accordance with previous observations for a CT. 90 While the values between the sampling campaigns vary widely, an increase in toxicity rather than elimination of toxicity is not uncommon and can be, for instance, caused by a deconjugation of phase II human metabolites. 98 Out of the three studies investigating progestogenic activity, only one study reported activities above the limit of detection (LOD). 31 Here, both advanced technologies are equally effective in reducing the residual progestogenic activity with a median removal of 88.9% and 81.1%, respectively (Figure 2) . In contrast, all four studies reported residual glucorticoid activity in conventionally treated wastewater above the LOD. On the basis of these studies, AC is more effective in reducing the glucocorticoid activity than ozonation with a median removal of 93.6% and 65.7%, respectively. However, because of the low sample size, this difference is not statistically significant (p = 0.131, Table S9 ).
3.2.4. Retinoid-like Activity. In addition to steroid receptors, environmental chemicals can disrupt retinoid signaling. 99 Retinoids control vertebrate morphogenesis, growth, cellular differentiation, and tissue homeostasis, 100 and an imbalance of retinoids and related substances can induce teratogenic effects in amphibians 101 and fish.
102
Retinoid acid receptor α (RARα) activity was frequently detected in (un)treated wastewater and surface waters. 82,103−105 Compared to that, retinoid X receptor (RXR) activity is less common. 106, 107 Nevertheless, RARα activity in conventionally treated wastewater is mostly low or below the LOD due to the effective removal by CT. 82, 103, 104 Three studies investigated retinoid-like activity during advanced wastewater treatment in five assays. 25, 34, 73 The first study reported no activity above the LOD for the RXR and RARα. 25 In contrast, Cao et al. observed a very effective reduction of RARα activity by ozonation, even at a low ozone dose of 2 mg L −1
. This observation is in line with the third study, which analyzed the performance of an ozone treatment in combination with a granulated activated carbon (GAC) post-treatment and reported a removal of RARα activity by 73.3% (SI Excel file).
3.2.5. Thyroid Signaling. Thyroid hormone signaling is essential for metabolism, growth, and organ development, including the brain. 108, 109 While some studies reported thyroid receptor α (TRα)activation by (un)treated wastewater, 107, 110 only four studies (5 assays) included advanced wastewater treatment technologies and detected no thyroid activity in the effluents of the CT or the advanced treatment. 25, 31, 34, 62 In contrast, in vivo studies with the Xenopus embryonic thyroid assay (XETA) suggest the occurrence of thyroid disruptors in conventionally treated wastewater, 111−113 which is not surprising, given that these compounds often act via nonreceptor-mediated mechanisms. 114 Thus, the XETA assay or in vitro bioassays for thyroid hormone biosynthesis (e.g., inhibition of the sodium-iodide symporter) 115 are more relevant than TRα activation to investigate the removal of thyroid disruptors by (advanced) wastewater treatment.
3.2.6. Hormone Receptor Antagonists. While most of the studies focus on agonistic activities of EDCs, a range of environmental contaminants including several herbicides (e.g., prochloraz), flame retardants (e.g., PBDEs), or nonsteroidal anti-inflammatory drugs (e.g., diclofenac, ibuprofen) are known to act as hormone receptor antagonists. 77, 116 Thus, antagonistic effects are relevant for the assessment of advanced wastewater treatment but considered in only nine studies. 25, 31, 34, [54] [55] [56] 59, 62, 67 Even though antagonistic effects can occur at any hormone receptor, only three studies included antagonistic effects at hormone receptors other than the estrogen and androgen receptors and observed no effects in all investigated effluents. 31, 34, 62 3.2.7. Antiandrogenicity. Nine studies covered antiandrogenicity in three assays. 25, 31, 34, [54] [55] [56] 59, 62, 67 Because the high agonistic activities in the influent usually mask antagonistic activities, no removal for the CT can be derived based on the available studies. Following an effective elimination of androgenicity by CT (Table 1) , four studies reported significant antiandrogenicity in the effluents, 25, 34, 55, 67 which is in line with several studies describing the presence of antiandrogenicity in conventionally treated wastewater 82, 117 and in the receiving river. 118, 119 Both advanced technologies reduce the antiandrogenic activities ( Figure 2 ). Ozonation (81.5%) is more effective than AC (62.4%), however, not significantly (p = 0.51, Table S9 ).
3.2.8. Antiestrogenicity. Seven studies included the end point antiestrogenicity (2 assays). 25, 31, 34, 54, 55, 62, 67 While three studies reported activities below the LOD, 31, 34, 62 an increase of antiestrogenicity in the course of advanced treatment was observed at four WWTPs ( Figure S1 ), 25, 54, 55, 67 which contradicts lab-scale experiments suggesting a good removal of antiestrogenicity by ozonation or AC. 120, 121 While bioassays detect the net effect of mixtures of agonists and antagonists, 122 the increase of antiestrogenicity may be explained by the improved removal of estrogenicity as previously observed for the opposite case. 49 However, in the case of ozonation, the antiestrogenicity appears to increase with elevated ozone doses, 25 which suggest the formation of antiestrogenic TPs, as recently described for tamoxifen. 123 No general conclusion about the effectiveness of the PTs in reducing antiestrogenicity can be drawn based on the available data. Sand filtration or GAC seems to reduce the antiestrogenicity of the effluents ( Figure S1 ). However, at one pilot plant (Neuss), a sand filtration led to a further increase in antiestrogenicity, 67 and at another pilot plant (Eriskirch), the GAC treatment reduced the antiestrogenicity only marginally. 54 Thus, further studies are required to understand the potential formation of antiestrogenicity and identify an appropriate PT.
3.2.9. Disruption of Hormone Biosynthesis. In addition to direct interactions with hormone receptors, several environmental contaminants are known to disrupt endocrine signaling via other than receptor-mediated mechanisms, for example, by binding to transport proteins or blocking enzymes involved in hormone synthesis. 124 However, in vitro assays for hormone biosynthesis were only performed at two advanced WWTPs, 31, 34 and only one study provides effect data. On the basis of this study, ozonation in combination with GAC further eliminates effects on steroidogenesis with a median removal of ≥80% (SI Excel file). 3.3. Beyond Endocrine End Points. Since EDCs represent only one group of micropollutants and several other mechanisms of action exist, 125 38 additional in vitro bioassays for 13 end points were applied to evaluate advanced wastewater treatment (Tables S7 and S8) .
3.3.1. Aryl Hydrocarbon Receptor (AhR) Activity. Because AhR activity is frequently detected in municipal wastewater, the end point was also included in eight studies (5 assays) on advanced wastewater treatment. 25, 34, 55, 60, 62, 67, 70, 71 The AhR is a ligand-activated factor involved in the regulation of xenobiotic metabolism, liver development, and female reproduction. 126 Because polycyclic aromatic hydrocarbons, polychlorinated biphenyls, furans, and dioxins are welldescribed AhR ligands, the activation of AhR is often referred to as dioxin-like activity. On the basis of the selected studies, the CT removes the AhR activity with a median removal of 74.5% (tab. 2). Nevertheless, residual AhR activity is still detectable in effluents. Given that the known AhR ligands are highly hydrophobic and, thus, should be well removed by sorption to the sludge particles, it remains unclear, which compounds are responsible for this effect. However, the promiscuous AhR can be activated by a wide range of structurally diverse compounds including hydrophilic substances. 127, 128 This is also reflected by ToxCast data with 13.8% of 3860 compounds activating the AhR. 18 Examples for wastewater-borne compounds are biocides, such as the fungicide propiconazole and the herbicide terbuthylazine.
3.3.2. Acetylcholinesterase (AchE) Inhibition. According to monitoring data from European rivers, neuroactive chemicals represent the largest group of target micropollutants with a known mechanism of action. 129 However, the AchE inhibition bioassay is the only neurotoxicity assay applied to advanced wastewater treatment. Given that AchE inhibition is the mechanism of action of several insecticides, such as organophosphates or carbamates, the assay represents a crucial insecticide marker, and four studies included this end point. 32, 65, 71, 72 On the basis of the selected studies, the CT reduces AchE inhibition with a median removal of 71.2% (Table 1) , which is in line with previously reported values. 85 However, the usefulness of applying this assay to wastewater is limited because a DOC > 2 mg L −1 , which is common in treated wastewater, can lead to false-positive results. 130 Ozonation reduces the effect by 52.1% (Figure 3 ). Moreover, a PT further increases the removal to 75.0%. No data is available for AC.
3.3.3. Combined Algae Assay. For the assessment of the occurrence and elimination of herbicides, the combined algae assay was applied in 11 studies. 13,24,29−32,34,62,70−72 Compared to the classic algae growth inhibition test (4.2), the combined algae assay is modified in a 96-well approach and includes the photosystem II (PSII) inhibition as additional end point. Since this is the mechanism of action of many herbicides (e.g., atrazine, diuron, terbutryn, simazine), the PSII inhibition correlates well with the herbicide content of wastewater. 13 The growth inhibition after 24 h can rather serve as a marker for unspecific toxicity because numerous other substances may cause this effect.
The experiments with the combined algae assay showed an effective removal of growth inhibition by CT (81.3%), while PSII inhibition is insufficiently eliminated (38.8%, Table 1 ), which is in accordance with previous observations for a CT. 85 Both advanced technologies further decrease the effects with a median removal of ≥77.3% (Figure 3) suggesting a good removal of herbicides. Moreover, a PT after ozonation does only marginally affect the removal of both end points.
3.3.4. Baseline Toxicity. In addition to specific mechanisms of action, many in vitro bioassays cover the baseline or nonspecific toxicity of wastewater. For this purpose, several studies analyzed the cytotoxicity of wastewater on different vertebrate cell lines (e.g., Hep-G2, CHO-9, or GH3). 57, 67 The Microtox assay in a 96-well format is an alternative approach. 131 In addition to cytotoxic effects on the bacteria, it also responds to a disruption of the energy budget and is often more sensitive than vertebrate cell lines. 53 Thus, we focused on the Microtox assay, which was applied in 11 studies on advanced WWTPs. 24,32,34,62,64−66,68,70−72 On the basis of these studies, the CT nearly eliminates the bacterial toxicity (92.1%, Table 1 ), which is in line with previously reported values. 85, 132 Ozonation further reduces the toxic effects by 50.4%. A subsequent PT further improved the reduction of bacterial toxicity with a median removal of 71.4% (Figure 3) . No data is available for AC.
3.3.5. Induction of Oxidative Stress Response. A broad spectrum of micropollutants induces an oxidative stress response; 99 thus, in vitro bioassays for this end point are increasingly applied to evaluate water quality and water treatment effectiveness. 4, 53, 132 However, only three studies investigate the reduction of oxidative stress responses by an advanced wastewater treatment in five assays. 34, 62, 66 Influents were only analyzed in one study. 66 On the basis of this study, the CT already eliminates the oxidative stress response effectively with a median removal of 87.1% (Table 1) , which is in accordance with previous values for CT. 132 With regard to the advanced WWTPs, one value is reported for the removal by ozonation alone (63.3%), and four values are reported for ozonation in combination with GAC, which vary widely, resulting in a median removal of 44.3% (Figure 3) . However, this variation is the result of the different detection limits of the assays (SI Excel file), and the majority of detected values (4/5) are in range or below the LOD, suggesting a good removal of compounds causing oxidative stress by an ozone treatment. Again, no data for AC is available.
3.3.6. Peroxisome Proliferator-Activated Receptors (PPARs). PPARs play essential roles in the regulation of cellular differentiation, development, and in particular, metabolism. 133 For instance, PPARγ is a key player in adipogenesis and lipid metabolism. 134, 135 Agonists of PPARγ (e.g., rosiglitazone or pioglitazone) are commonly used to treat type 2 diabetes. 136 In addition to specific pharmaceuticals, a broad spectrum of micropollutants (e.g., organotins or phthalates) activate PPARγ. 137 For the evaluation of advanced WWTPs, three studies included PPARγ activity. 31, 34, 62 However, only one of this study analyzed influent samples. 31 On this basis, CT already reduces most of the PPARγ activity (79.0%, Table 1 ). Regarding the advanced wastewater treatment technologies, only two studies detected PPARγ activity above the LOD. 31, 34 On the basis of these studies, AC (42%) is slightly more effective than ozonation (28.8%, Figure  3) , and a GAC treatment after ozonation leads to a slightly improved elimination (44.8%).
3.3.7. Pregnane X Receptor (PXR) and the Constitutive Androstane Receptor (CAR). PXR and CAR are both essential mediators of xenobiotic responses, such as the upregulation of genes that encode metabolizing enzymes (e.g., CYP3A). 138 Thus, the activation of both receptors represent an end point for xenobiotic metabolism. To date, the ecological implication of these end points is unknown. For the evaluation of advanced wastewater treatment technologies, only one study investigated PXR and CAR activation. 34 According to this study, ozonation combined with GAC reduce the PXR and CAR activity of the conventionally treated wastewater with a median removal of ≥77.8% (SI Excel file).
3.4. Genotoxicity and Mutagenicity. The majority of studies included bioassays targeting genotoxicity or mutagenicity in their assessment, which are often performed in the absence and presence of a liver enzyme mix (S9) to address metabolic activation. Especially for oxidative processes, both end points are highly relevant because inactive compounds can be transformed to genotoxic TPs, such as shown for the nontoxic metabolite of the fungicide tolylfluanid to Nnitrosodimethylamine (NDMA) during ozonation. 139, 140 Furthermore, most of the oxidants are rather consumed by the dissolved organic matter (DOM) than the micropollutants in wastewater, 141 which can lead to the formation of toxic oxygen-rich byproducts (e.g., aldehydes or ketones). 142, 143 In addition, if the wastewater contains comparatively high bromide concentrations (e.g., high industrial wastewater), an oxidative process will trigger the formation of bromate, which is a possible human carcinogen. 144−146 3.4.1. Genotoxicity. Twelve studies used the UmuC assay, which determines the induction of DNA repair mechanisms, to assess genotoxicity of the wastewater. 27,31,32,34,56,58,62,63,70−73 The extracts of conventionally treated wastewater were genotoxic in the majority of studies. Both advanced wastewater treatment processes lead to a considerable reduction of the genotoxicity. AC is more effective than ozonation with a median removal of 62.5% (−S9) and 86.8% (+S9) compared to 34.4% (−S9) and 64.7% (+S9), respectively (Figure 4 A) . A PT after ozonation further increases the removal of genotoxicity to 94.3% (−S9) and 80.5% (+S9).
Another option to study DNA damage is the comet assay, which has also been used to assess advanced wastewater treatment. 28, 57, 59, 63, 69, 147 After exposure to conventionally treated wastewater, no or only moderate effects were reported. With regard to the advanced technologies, the outcomes of the studies differ considerably. At two plants, a significant increase in DNA damage was found after ozonation, 63, 147 which indicates a formation of genotoxic TPs and contradicts the outcomes of the UmuC assay. In contrast, two studies reported no effects, 28, 57 one study reported an increased tail intensity after exposure to conventionally treated and ozonated wastewater, 59 and yet, another study a decrease of tail intensity in the course of ozonation. 69 In addition to variations in the wastewater composition, the main difference is that all studies that observed an effect in ozonated wastewater performed the comet assay with cells isolated from exposed organisms 59, 63, 147 instead of laboratory cell cultures. 28, 57, 69 Thus, DNA damage may manifest in vivo only, and future studies should perform the comet assay with isolated cells from intact organisms, preferably after chronic exposure.
A third option to assess genotoxicity is the micronucleus assay, which has been used by six studies to assess advanced WWTPs. 27, 28, 30, 34, 57, 69 Four studies reported a sporadic micronucleus formation, 27, 30, 34, 57 while in the majority of cases, the effluents of both CT and advanced technologies were not genotoxic (see SI section 3.3 for further information).
3.4.2. Mutagenicity. The Ames fluctuation test with the bacterium Salmonella typhimurium is widely applied to analyze mutagenicity and was included by 11 studies to evaluate advanced WWTPs. 24, 25, 27, 28, 30, 34, 54, 55, 62, 63, 69 Several strains responsive to different types of mutation exist. To assess wastewater, the standard strains TA98 (frameshift mutation) and TA100 (base pair mutation) are most commonly used. In addition, four studies also included the strain YG7108 25, 54, 55, 63 because of its high sensitivity to alkylating agents and nitrosamines. 148, 149 For the summary, we focused on the outcomes of these three frequently used strains, even though three studies used additional Ames strains (SI Excel file).
Mutagenic effects in conventionally treated wastewater and after advanced treatment were only sporadically detected in the standard strains TA98/100 ( Figure 4B ). In contrast, the strain YG7108 shows an increase of mutagenicity in the course of the ozone treatment in most of the samples, 25, 54, 55, 63 whereas no effects are detectable after AC. 63 These findings are further supported by a lab-scale study, which also observed a marked Figure 4 . Removal of genotoxicity in the UmuC assay by advanced wastewater treatment technologies compared to the activities present in the conventional treatment (A) and qualitative analysis of the mutagenicity in the Ames assay (B). A significant effect compared to the control is indicated in red including the number of experiments (green = no effect). The asterisk (*) indicates a reduction of mutagenicity that is still significantly increased compared to the control. AC = activated carbon treatment, CT = conventional treatment, PT = post-treatment, and ±S9 = with/without metabolic activation.
increase in mutagenicity after ozonation. 150 The mutagenic effect increased with an elevated ozone dose suggesting that the formation of mutagenic TPs causes this effect. 63 While nitrosamines are formed during ozonation, 139, 140 they can be ruled out as causative agents since the mutagenicity occurs without S9 ( Figure 4B ), and nitrosamines require metabolic activation to be mutagenic. 151 Thus, the mutagenic compounds remain unknown and deserve further research. A subsequent PT reduces the mutagenicity in all cases. Nevertheless, it is still significantly increased compared to the control, as well as to CT. Furthermore, no general conclusion about the effectiveness of the different PTs can be drawn based on the available data. While a biofilter with an expanded clay layer seems to be ineffective, 25, 55 sand filtration and a GAC treatment significantly reduce the mutagenicity. However, the effectiveness varies between these technologies, 54, 55, 63 and further investigations are required to identify an appropriate PT.
Comparison with Proposed Effect-Based Trigger Values (EBTs).
While it remains challenging to extrapolate ecological impacts of wastewater discharge based on in vitro data (see section 3), EBTs represent one way forward for including in vitro data in an assessment of water quality. However, these come with certain limitations: First, the link between in vitro end points and in vivo toxicity is weak in many cases (e.g., for xenobiotic metabolism). Second, the compounds triggering in vitro effects are often unknown (e.g., oxidative stress response). Thus, EBTs are based on the few known compounds for which in vivo data exist. Third, there is currently no consensus on how to derive EBTs (e.g., which type of in vivo data should be included), limiting their acceptance. Finally, defining a single threshold level for complex chemical−biological interactions will always be reductionist.
Taking a pragmatic approach, experts from an international network proposed a set of tentative EBTs to integrate in vitro data into a water quality assessment. As these are the only EBTs available for surface waters, we compared those to the extracted in vitro data. 46, 51 We identified seven EBTs for which sufficient data was available for advanced wastewater treatment: estrogenicity (0.4 ng EEQ/L), glucocorticoid activity (100 ng dexamethasone-EQ/L, GR-CALUX), AhR activity (50 pg TCDD-EQ/L, AhR-CALUX), PPARy activity (10 ng rosiglitazone-EQ/L, PPARγ-CALUX), PSII-inhibition (0.07 μg diuron-EQ/L, combined algae assay), bacterial toxicity (1246 μg TEQ/L, Microtox), and oxidative stress response (156 μg dichlorvos-EQ/L, AREc32 assay). To take all estrogenicity data into account, we used the bioassayindependent value of 0.4 ng EEQ/L, 152 which is in the range of bioassay-specific EBTs.
46,153 Nevertheless, we also performed the comparison with the assay-specific EBTs for estrogenicity ( Figure S2 ). For all other end points, we used assay-specific EBTs exclusively and compared these to the empirical data from the corresponding assay, only.
The bioassay equivalent concentrations for the CT exceed the proposed EBTs in the majority of cases: 100% of the PPARγ activity data (n = 3), followed by estrogenicity (89.7%, n = 68), AhR activity (87.5%, n = 8), PSII inhibition (84%, n = 25), oxidative stress response (66.7%, n = 3), bacterial toxicity (52%, n = 25), and glucocorticoid activity (40%, n = 5). Depending on the dilution, the highest risk to exceed the EBT in the receiving system exists for PPARγ activity with a 10-fold higher median BEQ in CT. This is followed by estrogenicity (3.9-fold), oxidative stress response (3.3-fold), AhR activity (2.8-fold), PSII inhibition (1.3-fold), bacterial toxicity (1.0-fold), and glucocorticoid activity (0.6-fold). To investigate further, we used the data set for estrogenicity because of its wealth of information to derive critical wastewater fractions in the receiving system ( Figure 5 ). To simplify, we assumed a linear dilution of the effect and neglected upstream contaminations.
On the basis of the EEQs in CT, the critical wastewater fractions for the 25th, 50th, and 75th percentiles are 38.2%, 22.7%, and 13.3%, respectively ( Figure 5A ). Especially under low flow conditions, these values are exceeded in a large number of European and U.S. surface waters, 154, 155 which is in line with studies modeling critical concentrations of individual wastewater-borne estrogenic substances in rivers. 154, 156 Both advanced wastewater treatment technologies reduce the median EEQ below the EBT (Figure 5 ). Accordingly, both treatment options will enable compliance with the proposed environmental quality criteria. Nevertheless, the lower reduction of estrogenicity by AC (see section 3.2) is also reflected in the critical wastewater fractions. Taking the 75th percentile of the EEQs in AC, a risk of exceeding the EBT still exists in surface waters receiving a wastewater fraction >64.3% ( Figure 5B ), which are rarely observed. 154, 155 Regarding the other end points, both advanced technologies reduce the median toxicities of the effluents far below the EBT for the end points PSII inhibition, glucocorticoid activity and for bacterial toxicity ( Figure S3 ). For the AhR-CALUX assay, the proposed EBT coincides with the LOD. Thus, most effects of the effluents of the advanced WWTPs are also in this area. While data on the removal of the oxidative stress response during advanced wastewater treatment is scarce, there is a general trend that it is effectively reduced (see section 3.3). The only available value for ozone is far below the EBT, whereas one of the two values for ozonation in combination with a PT is above ( Figure S3 ). In contrast, all PPARγ-CALUX BEQs of the effluents of the advanced technologies exceed the proposed EBT by more than 5-fold ( Figure S3 ). This suggests a remaining risk even after an upgrade. Nevertheless, because the EBT derivation by van der Oost et al. is based on the background BEQ, the proposed EBT can be rather used as an indicator of overall chemical stress than for a micropollutant risk. 51 Since in vitro data for (advanced) WWTPs is scarce (see section 3.3) and the causative PPARγ agonists remain largely unknown, 46 further knowledge is required to clarify this finding.
Overall, the available EBTs were crucial to distinguish between CT and advanced WWTPs. While the BEQs in the CT exceeded the EBTs in the majority of cases, advanced wastewater reduced the toxicity to a level largely below. Thus, as long other contamination sources contribute to a minor extent, the implementation of advanced wastewater treatment ensures compliance with the proposed environmental quality criteria for in vitro toxicity even at high wastewater fractions in the receiving ecosystem.
REDUCTION OF IN VIVO TOXICITY
An in vivo assessment aims at characterizing integrative, apical effects on end points like mortality, development, growth, reproduction, or behavior in aquatic key species representing the different trophic levels. 23 Initially developed for the risk assessment of single chemicals, in vivo bioassays are now widely used for investigating the toxicity of environmental samples, including wastewater either in laboratory or on-site flow-through systems. The latter integrates changes in chemical composition over time and avoids sample storage, transport, and treatment 157 but also increases the complexity and costs.
While in vivo bioassays integrate toxicokinetic and toxicodynamic processes, they provide only limited information about the underlying mechanisms.
23 This is particularly critical when evaluating wastewater because the organisms used in standardized in vivo studies are quite sensitive to the wastewater matrix (e.g., salinity, nutrients, or suspended organic matter). Thus, beneficial effects resulting from an additional nutrient or food supply may mask toxic effects caused by micropollutants, 158, 159 making it is impossible to differentiate between the two.
For the majority of model organisms, standardized test guidelines for determining acute and chronic toxicity exist. The latter is particularly relevant since the low micropollutant concentrations in wastewater from state-of-the-art WWTPs usually do not induce acute effects.
4.1. Data Availability. On the basis of our selection criteria, we identified 32 studies containing data from in vivo bioassays with 20 species (Table  S10) . 13,24−26,28−32,34,54−57,59,63,73,74,147,157,160−171 Since 29 out of the 32 studies exclusively analyzed aqueous samples, we focused on these and the most frequently used model organisms (see SI section 4.3 for less common species). Daphnids (Daphnia magna or Ceriodaphnia dubia) were most common (11 studies), followed by Danio rerio (8), Lemna minor (8), microalgae (8, see Table 2 for full list). For these 12 species, we extracted, in total, 219 data points for the CT, 201 for ozone, 224 for ozone + PT, and 51 for AC. 4.2.1. Algae. The algae growth inhibition experiments provide a heterogeneous picture. The majority of studies (6/8) did not observe an effect on the growth of Pseudokirchneriella subcapitata after exposure to wastewater from conventional and advanced treatment (Table 2) , which is in line with the outcomes of the combined algae assay (see section 3.3). In contrast, two studies with Desmodesmus subspicatus observed a persistent low growth inhibition after exposure to CT (<30%). While the first study observed no removal of the effect by the advanced treatments, 28 the second study reported an algae growth on control level after ozonation in combination with a fluid bed reactor (2/3 cases). 
Higher Plants.
In more than half of the laboratory experiments with L. minor (54%), a low growth inhibition (<30%) was reported after exposure to CT, which was not reduced by an additional ozone treatment (Table 2) . Moreover, three on-site experiments with L. minor indicate a slight increase of toxicity in the course of ozonation compared to the CT. In contrast, exposure to effluents of AC did not result in growth inhibition (Table 2) .
4.3. Invertebrate Toxicity. Twenty-two studies investigated the effects of wastewater on aquatic invertebrates. 24−26,28−32,54,55,59,73,74,147,157,163,165−167,169−171 In addition to acute toxicity in D. magna, all other methods use chronic exposure regimes. In addition to the classic reproduction test with D. magna and C. dubia, studies were carried out with the nonbiting midge Chironomus riparius, the benthic organism Lumbriculus variegatus, as well as the mud snail Potamopyrgus antipodarum. The majority of bioassays are standardized 175−179 but sometimes slightly modified for testing wastewater. Moreover, Gammarus fossarum as a key decomposer 180 was used in seven studies. 25, 29, 55, [165] [166] [167] 170 4.3.1. Daphnids. With one exception, 73 no acute toxicity was reported for D. magna exposed to wastewater from conventional and advanced treatment (Table 2) . Likewise, chronic exposure did not induce reproductive toxicity. 26, 28, 157, 169 Similarly, in the majority of experiments with C. dubia, no adverse effects were reported. However, in 19% of the experiments, the reproduction was negatively affected after exposure to CT. The occurrence of reproductive effect was lowest in the effluents of AC (11%) compared to ozonation (17%) and ozone + PT (27%). 4.3.2. Chironomus riparius. On-site experiments with the nonbiting midge C. riparius were conducted at two WWTPs. 147, 157 In both cases, no toxicity was detected after exposure to wastewater from CT, ozone, or AC.
4.3.3. Lumbriculus variegatus. Seven studies included onsite experiments with the sediment-dwelling oligochaete Lumbriculus variegatus. 24, 26, 28, 31, 147, 157, 169 Effects on reproduction occurred in 17% of the experiments in the CT and ozonated effluents, while no effects were observed after a PT or AC (Table 2) . Moreover, oligochaetes exposed to ozonated wastewater had a significantly reduced biomass compare to the CT in 50% of the experiments. This effect is associated with the formation of toxic oxidation byproducts. In all cases, a PT reduced this effect, underlining its importance as a barrier for toxic TPs. A significant reduction of biomass was also reported in one experiment after AC. Here, toxic TPs as a causal factor can be ruled out. 4.3.4. Potamopyrgus antipodarum. The chronic reproduction test with P. antipodarum was performed by one laboratory study 54 and by six studies in on-site, flow-through experiments. 25, 28, 54, 55, 147, 157 The laboratory experiments resulted in persistent reproductive toxicity after the CT, which was not reduced by advanced treatment (Table 2 ). In contrast, exposure to CT in seven on-site experiments resulted in a significant increase of fecundity, 25, 28, 147, 157 an effect that has been associated with exposure to residual estrogenic compounds. 181 While this is supported by parallel exposure to estrogenic compounds increasing reproduction, 28 ,157 a mechanistic link is missing because the molluskan steroid receptor orthologs are ligand-independent. 182 Both advanced wastewater treatment technologies reduced this effect in all cases (Table 2) .
4.3.5. Gammarus fossarum. A series of laboratory experiments with G. fossarum reported a significant reduction of feeding activity after exposure to CT. 166, 167 An ozone treatment coupled to sand filtration increased the feeding activity to control level suggesting an effective removal of this effect. In contrast, the feeding activity remained low in all Table 2 . Qualitative Analysis of the in Vivo Experiments a a A significant effect compared to the control is indicated in red including the number of experiments (no effect = green). * No effect after nutrients were spiked. AC = activated carbon treatment, CT = conventional treatment, and PT = post-treatment. effluents of AC. 167 The negative effect was recovered when spiking the respective effluents with nutrients. This suggests that nutrient limitation rather than micropollutants reduced the feeding activity. The findings are further supported by an on-site experiment in which a higher feeding activity and population size in ozonated wastewater compared to the CT was observed. 165 However, in a second on-site experiment at another WWTP, no alteration of the feeding activity was detected. 29 Furthermore, Wigh et al. reported a delayed molt cycle, reduced fecundity, and fertility of female gammarids exposed to CT, which were not reduced by an ozone treatment. 170 In addition, >90% of embryos exhibited developmental malformations. 170 4.4. Fish Toxicity. To assess adverse effects on fish, nine studies conducted the acute fish embryo toxicity test (FET) with zebrafish (Danio rerio) or Japanese medaka (Oryzias latipes), 28, 31, 32, 55, 59, 73, 74, 160, 163 which is standardized by the OECD. 183 One study each performed chronic, long-term experiments with D. rerio 56 and O. latipes. 74 Furthermore, to examine effects on the early stages of the development of rainbow trout (Oncorhynchus mykiss), the fish early life stage test (FELST) 184 was performed in on-site flow-through experiments.
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13, 24, 29, 31, 63, 164 Moreover, four studies investigated changes in gene expression of chronically exposed O. mykiss. 24, 161, 162, 168 4.4.1. Danio rerio. Most data is available for the FET with D. rerio. 28, 31, 32, 55, 59, 74, 163 Here, the exposure to wastewater from conventional and advanced treatment did not induce mortality in most cases (Table 2) . Hence, this test is not sensitive enough to detect effects of micropollutants. Moreover, one study assessed chronic toxicity on D. rerio 56 and analyzed vitellogenin (VTG) as a biomarker of exposure to estrogenic substances. Exposure to CT increased mortality, as well as VTG levels. Both advanced treatment technologies reduced these effects.
4.4.2. Oryzias latipes. Two studies performed the FET with O. latipes 73, 160 and reported an increased embryo mortality after exposure to CT. While in one study AC reduced this effect, 160 neither ozonation nor AC reduced the embryo toxicity in a second study. 73 Here, the ozone treatment further increased the mortality and induced a higher incidence of morphological abnormalities with an increasing ozone doses. 73 This observation contradicts the outcomes of a third study, 74 which performed a 21-day medaka screening assay for estrogenic and androgenic activities, and aromatase inhibition. 185 Here, the authors reported no mortality or any signs of diseases, as well as no estrogenic or androgenic effects after exposure to CT and ozone.
4.4.3. Oncorhynchus mykiss. The FELST test with O. mykiss was the most frequently applied assay to assess chronic fish toxicity. 13, 24, 29, 31, 63, 164 These investigations provide a heterogeneous picture. At the WWTP Regensdorf, the hatching success, swim-up behavior, and length and weight of the fish were impaired after the exposure to CT. 164 Here, the ozone treatment led to a significant increase in toxicity rather than a removal. These effects were again associated with the formation of toxic oxidation byproducts. A subsequent sand filtration reduced the effects to the level of the CT, and, thus, seems to be an effective barrier for the formed TPs. These findings are further support by investigations at the pilot plant Neuss. Here, ozonation significantly increased mortality and delayed the swim-up behavior compared to the CT, whereas the weight and the length were not affected. 63 In contrast, three studies conducted at the WWTP Lausanne, Basel, and Neugut reported positive effects of an ozone treatment on the early development of O. mykiss. 13, 24, 29, 31 At the WWTP Lausanne, all investigated end points were affected after exposure to CT, whereas, in Neugut, only a significantly increased mortality, and in Basel, a reduction of the weights and lengths of the fishes were observed. In all cases, an ozone treatment reduced these effects considerably. Importantly, no adverse effects were reported for AC (Table 2) .
Three out of the five studies also analyzed VGT. 29, 31, 164 In accordance with the findings in D. rerio, 56 VGT concentrations were significantly increased in fish exposed to CT, indicating the presence of estrogenic substances. Both advanced technologies reduced this effect in all cases, which is in line with the improved reduction of in vitro estrogenicity (section 3.2).
In addition to the FELST, gene expression analyses of chronically exposed O. mykiss were performed by four studies. 24, 161, 162, 168 At the WWTP Neugut, a broad spectrum of genes involved in estrogen response, xenobiotic metabolism, immune regulation, cell cycle control, as well as metal, oxidative, and general stress responses were investigated. 24 The majority of these genes was significantly upregulated after exposure to CT. Except for some genes for metal and oxidative stress, ozonation reduced the upregulation considerably, which is in line with the respective in vitro end points (sections 3.2 and 3.3). These findings are further supported by three studies at the pilot plant Stockholm, which reported similar outcomes for an ozonation. 161, 162, 168 In contrast, Cuklev et al. observed an induction of hsp70 as biomarker for a general stress in all fish exposed to ozonated effluents, which might be related to TP formation. 168 Importantly, none of the analyzed genes were differentially expressed in fish exposed to effluents of AC, which is in line with the absence of effects on apical end points in the FELST. (Table 2) , even though exposure to an undiluted CT effluent represents a worst-case scenario. In contrast, PR < GR < algae PSII inhibition are insufficiently reduced (<40%, Table 1), and significant in vitro activities at multiple end points can still be detected in the effluent of a CT. These residual toxicities exceed available EBTs for surface waters in the majority of cases and in accordance with previous studies. 46, 89, 186 This suggests that the discharge of conventionally treated wastewater can represent an environmental risk. The low critical wastewater fractions for estrogenicity further support this. Especially in surface waters in (semi)arid and densely populated regions, 154, 155 it will be difficult to comply with the proposed EBTs without implementing additional reduction measures. Although threshold values are absent, a residual environmental risk may also exist in vivo. Here, 92% of the reproduction experiments with P. antipodarum (n = 12), followed by the feeding activity test with G. fossarum (88%, n = 8), FELST with O. mykiss (60%, n (Figures 2 and 3) . Here, the performance of AC and ozone treatment do not differ significantly for all studied end points (Table S9) . Moreover, the effluent toxicities of the advanced treatment were mainly below the EBTs with the exception of PPARγ activity. Thus, an upgrade leads to a significant, additional detoxification and enables compliance with proposed environmental quality criteria even at high wastewater fractions in the receiving surface water. Similar to the effective removal of in vitro toxicity, advanced wastewater treatment also significantly reduces in vivo toxicity. These included the experiments with G. fossarum and O. mykiss FELST at the WWTPs in Lausanne, Basel, and Neugut. Moreover, the VGT analyses in exposed fish, as well as the on-site experiments with P. antipodarum, suggest that the effective removal of in vitro estrogenicity by both technologies (Figure 2 ) also results in a reduction of the corresponding in vivo effects. These positive findings are in line with field studies reporting an improvement of biodiversity, 187 ecosystem functions, 188 and fish health 60, 189 after implementing an advanced treatment technology. 5.3. Ozonation Generates Toxicity That Can Be Removed by a Post-Treatment. Notably, several studies reported increased in vitro and in vivo toxicity in the effluent of an ozone treatment. These include genotoxicity and mutagenicity (section 3.4), the growth of L. minor and biomass of L. variegatus, as well as embryo toxicity in O. latipes and effects on the early development of O. mykiss (Table 2 ). These observations are associated with the formation of toxic TPs. However, the specifics of this formation, as well as the causative compounds, remain to be elucidated. Thus, from an ecotoxicological perspective, AC is preferable to ozonation because it is comparably effective in removing toxicity without generating toxic TPs. Nevertheless, an ozone treatment has additional benefits, including disinfection 190−192 and lower implementation and maintenance costs, 193, 194 which is also reflected by the larger number of studies (573 data points) compared to the number of studies for AC treatment (162 data points).
The literature suggests that an ozone treatment should only be implemented with a subsequent PT to remove the generated TPs. While various PTs were assessed (Tables S4  and S5 ), comparison of their relative performance is difficult because data for some options is scarce (e.g., fix and fluid bed reactor) and only a few studies compare different PTs in parallel. [24] [25] [26] 54, 55, 169 The combination with a GAC filter can lead to significant, additional micropollutant removal via sorption, 195 while all other PTs are solely based on biological degradation. Accordingly, GAC filters outperformed conventional filters, as well as fix and fluid bed reactors, in removing micropollutants, TPs, and mutagenicity. 196, 55, 197 However, considering the limited data and given that the performance in reducing toxicity differs significantly between studies, further investigations are required to identify an optimal PT. 5.4. What are the Sensitive End Points and Species? Certain end points, especially estrogenicity (27% of all data), dominate the in vitro assessment, whereas certain animal models, such as daphnids (24% of all data) are overrepresented in the in vivo data. Conventionally treated wastewater triggers multiple in vitro end points, including estrogenicity, glucocorticoid activity, AhR activity, neuro-and phytotoxicity, oxidative stress response, as well as baseline toxicity. In terms of chronic in vivo effects, P. antipodarum, G. fossarum, and O. mykiss are the most sensitive species. Thus, these end points and species are suitable to investigate an additional removal of toxicity by advanced technologies. In addition, mutagenicity with the Ames strain YG7108, genotoxicity in the comet assay with cells from exposed organisms, and biomass of L. variegatus after chronic exposure represent sensitive end points to investigate the formation of toxic TPs during ozonation.
In contrast, progestogenic and thyroid receptor activity are rarely observed. Moreover, short-term in vivo bioassays and certain species (daphnids, C. riparius) are not sensitive enough to detect toxic effects of conventionally treated wastewater.
5.5. Future Research Needs. On the basis of this systematic review, we recommend the following:
• Research should focus on toxicity reduction by an AC treatment, as well as by multiple ozonation PTs, to balance current biases in knowledge.
• Given the wealth of estrogenicity data, future research should focus on underrepresented end points, including unspecific xenobiotic sensors (PPAR, PXR, CAR) and specific end points (retinoid-like, steroidogenesis, and neurotoxicity) with established links to in vivo impacts.
• A well-designed battery of in vitro bioassays is needed to assess advanced wastewater treatment, considering commonly detected end points, as well as cellular toxicity and adverse outcome pathways, to link effects to higher levels of biological organization.
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• Given their limited sensitivity, short-term in vivo assays are not suitable for evaluating toxicity reduction during advanced wastewater treatment when aqueous samples are analyzed. Here, testing extracted water samples might represent an alternative.
• Model organisms for an in vivo assessment should be selected on the basis of their sensitivity to the toxicity present in the CT. This excludes daphnids and chironomids and includes P. antipodarum, G. fossarum, and O. mykiss. • The toxicity removal by the CT should serve as one critical parameter to determine if an upgrade to WWTPs is needed.
• EBTs are useful to benchmark the toxicity removal.
Here, some tentative EBTs need to be refined (e.g., PPARγ activity) and missing EBTs established (e.g., antiestrogenicity).
• The PPARγ activity in effluents of an advanced treatment exceeds the EBT by 5-fold. Because this is based on limited data, the PPARγ activity deserves more attention.
• If toxicity elimination is a major aim of wastewater treatment, advanced technologies based on ozonation or AC represent suitable options to achieve that goal.
• Because ozonation generates toxic byproducts, a PT needs to be implemented. Here, future research should focus on a comparative assessment of the available technologies. To conclude, the literature highlights that toxicity removal is a crucial aspect of benchmarking the performance of 
